Observations placeholder
Mycelex and Clotrimazole
Identifier
019558
Type of Spiritual Experience
Background
A description of the experience
Clotrimazole (brand name Canesten or Lotrimin) is an antifungal medication commonly used in the treatment of fungal infections (of both humans and other animals) such as vaginal yeast infections, oral thrush, and ringworm. It is also used to treat athlete's foot and jock itch.
Side effects
Side effects of the oral formulation include itching, nausea, and vomiting. >10% of patients using the oral formulation may have abnormal liver function tests. For this reason, liver function tests should be monitored periodically when taking the oral clotrimazole (troche). When used to treat vulvovaginal candidiasis (yeast infection), <10% of patient have vulvar or vaginal burning sensation. <1% of patients have the following side effects: Burning or itching of penis of sexual partner; polyuria; vulvar itching, soreness, edema, or discharge
Clotrimazole creams and suppositories contain oil which may weaken latex condoms and diaphragms.
On Jan, 7, 2016: 1,492 people reported to have side effects when taking Mycelex. Among them, 5 people (0.27%) have Hallucination.
On Mar, 7, 2016: 2,987 people reported to have side effects when taking Clotrimazole. Among them, 8 people (0.27%) have Hallucination.
On Apr, 1, 2016: 585 people reported to have side effects when taking Lotrimin. Among them, 1 people (0.17%) has Hallucination.
On Jan, 7, 2016: 1,492 people reported to have side effects when taking Mycelex. Among them, 55 people (3.69%) have Death.
Time on Mycelex when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 25.00% | 75.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Mycelex :
Female | Male | |
Death | 64.81% | 35.19% |
Age of people who have Death when taking Mycelex :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Death | 0.00% | 0.00% | 0.00% | 4.35% | 34.78% | 21.74% | 13.04% | 26.09% |